NCT01974440 2025-05-25SELENEJanssen Research & Development, LLCPhase 3 Completed403 enrolled 23 charts
NCT01889069 2020-08-13A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)Hoffmann-La RochePhase 3 Completed159 enrolled 24 charts